A novel cytotoxic anti-B7-H3 affibody with therapeutic potential in acute myeloid leukemia.

Front Pharmacol · 2025 · PMC12464454 · PMID 41019995

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

The difference in the inhibition effect between RAJI and THP-1 was statistically significant for the 25 μM treatment ( p < 0.01) and highly significant for the 50 μM and 100 μM treatments ( p < 0.001), as shown in Figure 4B .

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.